Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporine-A can cause excessive hair growth, which usually stops after discontinuing the drug.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Cyclosporine A can help some people with severe alopecia areata regrow hair.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Low-Level Laser Therapy and other light treatments for hair growth lack strong evidence and need more research.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Current research explores hair growth drugs, while future research aims for personalized treatments.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Understanding normal hair growth and loss in children is key to diagnosing and treating hair disorders.

Chemotherapy-induced hair loss is a major concern, but various treatments show promise in preventing and reversing it.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Vitamin A might be a safe extra treatment for dogs with sebaceous adenitis, but more research is needed to prove its effectiveness.

Cyclosporin A promotes hair growth in mice and increases a protein linked to hair growth, but it may not work the same way in humans.

Transplant patients face higher skin cancer risks due to immunosuppressive therapy, requiring careful skin health monitoring.

Mycophenolate mofetil was effective for most patients in treating scarring hair loss, but some had side effects.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Treating cystoid macular oedema in uveitis is difficult and risky.

PRP treatment may help with alopecia areata, especially in newer cases.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

The combination of minoxidil and cyclosporine improved hair growth in short anagen syndrome.

Turkish pregnant women commonly experienced skin issues like itching and acne, and doctors mainly used topical treatments due to safety concerns during pregnancy.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Certain medications can impact metabolic syndrome, with some improving conditions like high blood sugar and others having no effect.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.